Background The incremental economic burden of US adults with major depressive disorder
(MDD) was estimated at US210.5billionin2010(year2012values) …

Major Depressive Disorder (MDD) is one of the most burdensome illnesses globally, with
significant negative impacts on activities of daily living, quality of life, cognitive function, and …

Background: The economic burden of depression in the United States—including major
depressive disorder (MDD), bipolar disorder, and dysthymia—was estimated at $83.1 billion …

Depression imposes significant costs on sufferers, their families and care-givers, employers
and insurance payers. This article summarises medical and health economics literature …

Background: The economic burden of depression was estimated to be $43.7 billion in 1990.
A subsequent study reported a cost burden of $52.9 billion using revised prevalence data …

Objectives To characterize the health-care utilization and economic burden associated with
depression in Manitoba, Canada. Methods Patient-level data were retrieved from the …

BACKGROUND: Major depressive disorder (MDD) is a leading cause of disability, morbidity,
and mortality worldwide. The lifetime prevalence in the United States is estimated at 17 …

Major depression is a commonly occurring, seriously impairing, and often recurrent mental
disorder. 1, 2 The World Health Organization (WHO) ranks major depressive disorder (MDD) …

Context After marked increases from 1987 to 1997, trends in depression treatment in the
United States increased modestly from 1998 to 2007. However, multiple policy changes that …

Background: Depressive disorder is treatable but costly, thus influencing quality of life of
people. Aim: Determine direct and indirect costs incurred by depressive disorder in …